Your browser doesn't support javascript.
loading
AZD4547 targets the FGFR/Akt/SOX2 axis to overcome paclitaxel resistance in head and neck cancer.
Aytatli, Abdulmelik; Barlak, Neslisah; Sanli, Fatma; Caglar, Hasan Onur; Gundogdu, Betul; Tatar, Arzu; Ittmann, Michael; Karatas, Omer Faruk.
Afiliação
  • Aytatli A; Department of Molecular Biology and Genetics, Erzurum Technical University, Omer Nasuhi Bilmen Mah. Havaalani Yolu Cad. No: 53 Yakutiye, Erzurum, Turkey.
  • Barlak N; Molecular Cancer Biology Laboratory, High Technology Application and Research Center, Erzurum Technical University, Erzurum, Turkey.
  • Sanli F; Department of Molecular Biology and Genetics, Erzurum Technical University, Omer Nasuhi Bilmen Mah. Havaalani Yolu Cad. No: 53 Yakutiye, Erzurum, Turkey.
  • Caglar HO; Molecular Cancer Biology Laboratory, High Technology Application and Research Center, Erzurum Technical University, Erzurum, Turkey.
  • Gundogdu B; Department of Molecular Biology and Genetics, Erzurum Technical University, Omer Nasuhi Bilmen Mah. Havaalani Yolu Cad. No: 53 Yakutiye, Erzurum, Turkey.
  • Tatar A; Molecular Cancer Biology Laboratory, High Technology Application and Research Center, Erzurum Technical University, Erzurum, Turkey.
  • Ittmann M; Department of Molecular Biology and Genetics, Erzurum Technical University, Omer Nasuhi Bilmen Mah. Havaalani Yolu Cad. No: 53 Yakutiye, Erzurum, Turkey.
  • Karatas OF; Department of Medical Pathology, Faculty of Medicine, Ataturk University, Erzurum, Turkey.
Cell Oncol (Dordr) ; 45(1): 41-56, 2022 Feb.
Article em En | MEDLINE | ID: mdl-34837170

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Resistencia a Medicamentos Antineoplásicos / Proteínas Proto-Oncogênicas c-akt / Neoplasias de Cabeça e Pescoço Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cell Oncol (Dordr) Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Resistencia a Medicamentos Antineoplásicos / Proteínas Proto-Oncogênicas c-akt / Neoplasias de Cabeça e Pescoço Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cell Oncol (Dordr) Ano de publicação: 2022 Tipo de documento: Article